Elaine Studer
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Hepatology top 5%
- Liver physiology and pathology
Papers in
- Oncology 15
- Drug Transport and Resistance Mechanisms 14
-
- Sphingolipid Metabolism and Signaling 4
- Co-authors
- Phillip B. Hylemon (20 shared papers)Paul Dent (14 shared papers)William M. Pandak (15 shared papers)Seema Gupta (9 shared papers)Huiping Zhou (14 shared papers)Emily C. Gurley (8 shared papers)Steven Grant (8 shared papers)Philip B. Hylemon (7 shared papers)
- Journals
- Hepatology (8 papers)Journal of Biological Chemistry (5 papers)The FASEB Journal (2 papers)PLoS ONE (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Elaine Studer
40 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 90
- Oncology 882
- Hepatology 238
- Pharmacology 245
- Molecular Medicine 87
- Epidemiology 518
Countries citing papers authored by Elaine Studer
This map shows the geographic impact of Elaine Studer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine Studer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine Studer more than expected).
Fields of papers citing papers by Elaine Studer
This network shows the impact of papers produced by Elaine Studer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine Studer. The network helps show where Elaine Studer may publish in the future.
Co-authors
The 25 scholars most cited alongside Elaine Studer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 254 | |
| 2 | 2001 | 195 | |
| 3 | 1991 | 167 | |
| 4 | 2008 | 140 | |
| 5 | 2002 | 120 | |
| 6 | 2008 | 120 | |
| 7 | 2004 | 110 | |
| 8 | 2005 | 101 | |
| 9 | 2002 | 86 | |
| 10 | Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin. | 1979 | 83 |
| 11 | 1989 | 77 | |
| 12 | 2009 | 75 | |
| 13 | 2010 | 74 | |
| 14 | 2004 | 70 | |
| 15 | 2007 | 69 | |
| 16 | 2010 | 65 | |
| 17 | 2009 | 60 | |
| 18 | 1979 | 54 | |
| 19 | 2004 | 51 | |
| 20 | 2004 | 48 |
About Elaine Studer
Elaine Studer is a scholar working on Oncology, Molecular Biology, Surgery, Epidemiology and Immunology, having authored 40 papers that have together received 2.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Sphingolipid Metabolism and Signaling (4 papers), HIV-related health complications and treatments (4 papers), Complement system in diseases (4 papers) and HIV Research and Treatment (4 papers). The work is most often cited by research in Oncology (882 citations), Hepatology (238 citations), Pharmacology (245 citations), Molecular Medicine (87 citations) and Epidemiology (518 citations). Elaine Studer has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Phillip B. Hylemon, Paul Dent, William M. Pandak, Seema Gupta, Huiping Zhou, Emily C. Gurley, Steven Grant, Philip B. Hylemon, Youwen Fang and Daniel H. Conrad. Their work appears in journals such as Hepatology, Journal of Biological Chemistry, The FASEB Journal, PLoS ONE and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.